New Insights In Hematology, Venice, Italy, May 1-4 1996: Selection and transplantation of autologous hematopoietic CD34+ cells for patients with multiple myeloma

Leukemia and Lymphoma

Volumn 26, Issue SUPPL. 1, 1997, Pages 1-11

  Lemoli, Roberto M ^a   Fortuna, Alessandra ^a   Raspadori, Donatella ^a   Ventura, Maria Alessandra ^a   Martinelli, Giovanni ^a   Gozzetti, Alessandro ^a   Leopardi, Giuliana ^a   Ratta, Marina ^a   Cavo, Michele ^a   Tura, Sante ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Autologous transplantation; CD34+ cells; Multiple myeloma

Indexed keywords

AVIDIN; BIOTIN; BUSULFAN; CD19 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CYCLOPHOSPHAMIDE; DNA; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

APHERESIS; AUTOTRANSPLANTATION; B LYMPHOCYTE; CELL POPULATION; CELL SELECTION; CLINICAL ARTICLE; COLONY FORMING UNIT GM; CONFERENCE PAPER; CRYOPRESERVATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNOADSORPTION; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN GENE; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; MINIMAL RESIDUAL DISEASE; MULTIPLE MYELOMA; NATURAL KILLER CELL; PLASMA CELL; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; WHOLE BODY RADIATION;

EID: 7144227968     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (32)

1. Attal, M., Harousseeau, J. L., Stoppa, A. M., Sotto, J. L., Fuzibet, G., Rossi, J. F., Casassus, P., Thyss, A., Maisonneuve, H., Facon, T., Ifrah, N., Payen, C. and Bataille. R. (1994). High-dose therapy in multiple myeloma: A prospective randomized study of the "Intergroupe francais du myelome" (IFM). Blood, 84, 386a (abstr.)
2. To, L. B. (1993). Is our current strategy in manipulating hemopoiesis in autologous transplantation correct? Stem Cells, 11, 283-289.
3. Fermand, J. P., Chevert, S., Ravaud, P., Divine, M., Leblond, V., Dreyfus, F., Mariette, X. and Brouet, J. C. (1993) High dose chemoradiotherapy with autologous blood stem cell transplantation in multiple myeloma. Results of a phase II trial involving 63 patients. Blood, 82, 2005-2009.
4. Vesole, D. H., Barlogie, B., Jagannath, S., Cheson, B., Tricot, G., Alexanian, R. and Crowley, J. (1994). High-dose therapy for refractory multiple myeloma: Improved prognosis with better supportive care and double transplant. Blood. 84. 950-956.
5. [51 Berenson, J., Wong, R., Kim, K., Brown, N. and Lichstentein, A. (1987). Evidence of peripheral blood B-lymphocyte but not T-lymphocyte involvement in multiple myeloma. Blood, 70, 1550-1564.
6. Pilarski, L. M. and Jensen, G. S. (1992). Monoclonal circulating B-cells in multiple myeloma: A continuously differentiating possibly invasive population as defined by expression of CD45 isoforms and adhesion molecules. Hematology/ Oncology Clinics of North America, 6, 297-322.
7. Bergui, L., Schena, M., Gaidano, G. L., Riva, M. and Caligaris-Cappio, F. (1989). Interleukin 3 and Interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma. J Exp Med, 170, 613-618.
8. Pilarski, L. M. and Belch, A. R. (1994). Circulating monoclonal B cells expressing P glycoprotein may be a reservoir of multidrug-resistant disease in multiple myeloma. Blood. 83, 724-736.
9. Cavo, M., Benni, M., Cirio, T. M., Gozzetti, A. and Tura, S. (1995). Allogeneic bone marrow transplantation for the treatment of multiple myeloma. An overview of published reports. Stem Cells, 13 (suppl. 2), 126-131.
10. Tricot, G., Vesole, D. H., Jagannath, S., Hilton. J., Munshi, N. and Barlogie, B. (1996). Graft-versus-myeloma effect: Proof of principle. Blood, 87, 1196-1198.
11. Brenner, M. K., Rill, D. R., Moen, R. C., Krance. R. A., Mirro, J., French Anderson, W. and Ihle, J. N. (1993). Gene-marking to trace the origin of relapse agter autologous bone-marrow transplantation. Lancet, 341, 85-86.
12. + cells to remove circulating tumor cells. Blood, 87, 1625-1634.
13. Benini, C., Bandini. G., Motta, M. R., Belardinelli, A. R., Calori, E., Rizzi, S., Martinelli, G., Rosti, G., Trabetti. E., Pignatti, P. and Tura, S. (1993). Donor origin of hematopoiesis after a case of allogeneic transplantation with cryopreserved marrow. Haematologica, 78, 414-415.
14. Lemoli, R. M., Gasparetto, C., Scheinberg, D. A., Moore, M. A. S., Clarkson, B. D. and Gulati, S. C. (1991). Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combination. Blood, 77, 1829-1836.
15. Lemoli, R. M., Fortuna, A., Grande, A., Gamberi, B., Bonsi, L., Fogli, M., Amabile, M., Cavo, M., Ferrari, S. and Tura, S. (1994). Expression and functional role of c-kit ligand (SCF) in human multiple myeloma. Br J Haematol, 88, 760-769.
16. + peripheral blood progenitor cells after high dose chemotherapy for patients with advanced multiple myeloma. Blood, 86, 390-397.
17. Brisco, M. J., Tan, L. W., Orsborn, A. M. and Morley, A. A. (1990). Development of a highly sensitive assay, based on the polymerase chain reaction, for rare B-lymphocyte clones in a polyclonal population. Br J Haematol, 75, 163-167.
18. Martinelli, G., Buzzi, M., Zaccaria, A., Mantovani. V., Farabegoli, P., Calori, E., Bandini, G., Bragliani, M., Barboni, P., Panzica, G. and Tura, S. (1993). New strategies for selection of unrelated bone marrow donors. Bone Marrow Transplantation, 11, 31-32.
19. Tomlinson, I. M., Walter, G., Marks, J. D., Llewelyn, M. B. and Winter, G. (1992). The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops. J Mol Biol, 227, 776-781.
20. Ravetech, J. V., Siebenlist, U., Korsmeyer, S., Waldman, T. and Leder, P. (1981). Structure of the human immunoglobulin locus: characterisation of embrionic and rearranged J and D genes. Cell, 27, 583-591.
21. Kwok, S. and Higuchi, R. (1989). Avoiding false positives with PCR. Nature, 339, 237.
22. Gianni, A. M., Bregni, M., Stern, A., Siena, S., Tarella, C., Pileri, A. and Bonadonna, G. (1989). Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet, ii, 580-584.
23. Deisseroth, A. B., Zu, Z., Claxton, D. and Hanania, E. G., Fu, S., Ellerson, D., Goldberg, L., Thomas, M., Janicek, K., French Anderson, W., Hester, J., Korbling, M., Durett, A., Moen, R., Berenson, R., Heimfeld, S., Hamer, J., Calvert, L., Tibbits, P., Talpaz, M., Kantarjian, H., Champlin, R. and Reading, C. (1994). Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood, 83, 3068-3076.
24. Carlo Stella, C., Cazzola, M., De Fabritiis, P., De Vincentiis, A., Gianni, A. M., Lanza, F., Lauria, F., Lemoli, R. M., Tarella, C., Zanon, P. and Tura, S. (1995). CD34-Positive cells: Biology and clinical relevance. Haematologica, 80, 367-387.
25. Berenson, R. J., Bensinger, W. I., Andrews, R. G., Kalamasz, D., Hill, R. and Bernstein, I. D. (1987). Hematopoietic stem cell transplants. In: Recent advances in leukemia and lymphoma, (eds.) R. P. Gale and D. W. Golde, UCLA Symposia on molecular and cellular biology. New Series (vol. 61) pp. 527 (Wiley-Liss, New York).
26. Watt, S. M., Karhi, K., Gatter, K., Furley, A. J. W., Katz, F. E., Healy, L. E., Altass, L. J., Bradley, N. J., Sutherland, D. R., Levinsky, R. and Greaves, M. F. (1988). Distribution and epitope analysis of the cell membrane glycoprotein (HPCA-l) associated with human hematopoietic progenitor cells. Leukemia, 1, 417-424.
27. Takishita, M., Kosaka, M., Goto, T. and Saito, S. (1994). Cellular origin and extent of clonal involvement in multiple myeloma: genetic and phenotypic studies. Br J Haematol, 87, 735-742.
28. Sahota, S., Hamblin, T., Oscier, D. G. and Stevenson, F. K. (1994). Assessment of the role of clonogenic B-lymphocytes in the pathogenesis of multiple myeloma. Leukemia, 8, 1285-1289.
29. Vescio, R. A., Hong, C. H., Cao, J., Kim, A., Schiller, G. J., Lichtenstein, A. K., Berenson, R. J. and Berenson, J. R. (1994). The hematopoietic stern cell antigen, CD34, is not expressed on the malignant cells in multiple myeloma. Blood, 84, 3283-3290.
30. + stem cells do not contain clonal myeloma cells. Blood, 86, 381-389.
31. - lymphoid cells and the purging efficiency is increased by anti-CD2 and anti-CD30 immunotoxins. Bone Marrow Transplantation, 13,465-471.
32. (32] Gobbi, M., Cavo, M., Tazzari, P. L., Dinola, A., Tassi, C., Bontadini, A., Albertazzi, L., Miggiano, M. C., Rizzi, S., Rosti, G., Bolognesi, A., Stirpe, F. and Tura, S. (1989). Autologous bone marrow transplantation with immunotoxinpurged marrow for advanced multiple myeloma. Eur J Haematol, 43 (Suppl. 51), 176-181.